美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=CLARISCAN"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
CLARISCAN 210016 001 ANDA GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS 3.769GM/10ML (376.9MG/ML) No No 2019/11/01 2019/11/01 GE HEALTHCARE Prescription
CLARISCAN 210016 002 ANDA GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS 5.6535GM/15ML (376.9MG/ML) No No 2019/11/01 2019/11/01 GE HEALTHCARE Prescription
CLARISCAN 210016 003 ANDA GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS 7.538GM/20ML (376.9MG/ML) No No 2019/11/01 2019/11/01 GE HEALTHCARE Prescription
CLARISCAN 210016 004 ANDA GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS 37.69GM/100ML (376.9MG/ML) No No 2019/11/01 2020/08/04 GE HEALTHCARE Prescription
CLARISCAN 210016 005 ANDA GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS 1.8845GM/5ML (376.9MG/ML) No No 2019/11/01 2020/11/24 GE HEALTHCARE Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database